Bristol-Myers Reports Received Positive CHMP Opinion for Opdivo for Treatment of Adults with Relapsed or Refractory Classical Hodgkin Lymphoma After Autologous Stem Cell Transplant and Treatment With Brentuximab Vedotin
Paul Quintaro